Pediatr. praxi. 2020;21(5):311-314 | DOI: 10.36290/ped.2020.063

Hemolytic-uremic syndrome by children

doc. MUDr. Jakub Zieg, Ph.D.
Pediatrická klinika 2. LF a FN v Motole, Praha

Hemolytic-uremic syndrome (HUS) is thrombotic microangiopathy characterised by the presence of acute kidney injury, nonimmune hemolytic anemia and thrombocytopenia. It is one of the most common cause of pediatric acute kidney injury. Our current understanding of the pathogenesis of HUS along with modern diagnostic and therapeutic methods significantly improved outcomes of affected patients. This review summarizes the current state of knowledge of the topic.

Keywords: hemolytic-uremic syndrome, children, diagnostics, complement, management.

Published: October 16, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zieg J. Hemolytic-uremic syndrome by children. Pediatr. praxi. 2020;21(5):311-314. doi: 10.36290/ped.2020.063.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin‑producing Escherichia coli. The Journal of infectious diseases 1985; 151: 775-782. Go to original source... Go to PubMed...
    2. Buchholz U, Bernard H, Werber D, Bohmer MM, Remschmidt C, Wilking H, Delere Y, an der Heiden M, Adlhoch C, Dreesman J, Ehlers J, Ethelberg S, Faber M, Frank C, Fricke G, Greiner M, Hohle M, Ivarsson S, Jark U, Kirchner M, Koch J, Krause G, Luber P, Rosner B, Stark K, Kuhne M. German outbreak of Escherichia coli O104:H4 associated with sprouts. The New England journal of medicine 2011; 365: 1763-1770. Go to original source... Go to PubMed...
    3. Jokiranta TS HUS and atypical HUS. Blood 2017; 129: 2847-2856. Go to original source... Go to PubMed...
    4. Sheerin NS, Glover E. Haemolytic uremic syndrome: diagnosis and management. 2019; F1000 Research 8.
    5. Zieg J, Dusek J, Marejkova M, Limrova P, Blazek D, Pavlicek P, Grega M, Janda J, Blahova K. Fatal case of diarrhea‑associated hemolytic uremic syndrome with severe neurologic involvement. Pediatrics international: official journal of the Japan Pediatric Society 2012; 54: 166-167. Go to original source... Go to PubMed...
    6. Spinale JM, Ruebner RL, Copelovitch L, Kaplan BS. Long‑term outcomes of Shiga toxin hemolytic uremic syndrome. Pediatric nephrology 2013; 28: 2097-2105. Go to original source... Go to PubMed...
    7. Wijnsma KL, van Bommel SA, van der Velden T, Volokhina E, Schreuder MF, van den Heuvel LP, van de Kar NC. Fecal diagnostics in combination with serology: best test to establish STEC‑HUS. Pediatric nephrology 2016; 31: 2163-2170. Go to original source... Go to PubMed...
    8. Walsh PR, Johnson S. Treatment and management of children with haemolytic uraemic syndrome. Archives of disease in childhood 2018; 103: 285-291.Další literatura u autoraa na www.pediatriepropraxi.cz Go to original source... Go to PubMed...
    9. Kakoullis L, Papachristodoulou E, Chra P, Panos G. Shiga toxin‑induced haemolytic uraemic syndrome and the role of antibiotics: a global overview. The Journal of infection 2019; 79: 75-94. Go to original source... Go to PubMed...
    10. Karnisova L, Hradsky O, Blahova K, Fencl F, Dolezel Z, Zaoral T, Zieg J. Complement activation is associated with more severe course of diarrhea‑associated hemolytic uremic syndrome, a preliminary study. European journal of pediatrics 2018; 177: 1837-1844. Go to original source... Go to PubMed...
    11. Walsh PR, Johnson S. Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome. Pediatric nephrology 2019; 34: 1485-1492. Go to original source... Go to PubMed...
    12. Klein PJ, Bulla M, Newman RA, Muller P, Uhlenbruck G, Schaefer HE, Kruger G, Fisher R. Thomsen‑Friedenreich antigen in haemolytic‑uraemic syndrome. Lancet 1977; 2: 1024-1025. Go to original source... Go to PubMed...
    13. Bitzan M, AlKandari O, Whittemore B, Yin XL. Complement depletion and Coombs positivity in pneumococcal hemolytic uremic syndrome (pnHUS). Case series and plea to revisit an old pathogenetic concept. International journal of medical microbiology: IJMM 2018; 308: 1096-1104. Go to original source... Go to PubMed...
    14. Copelovitch L, Kaplan BS. Streptococcus pneumoniae‑associated hemolytic uremic syndrome. Pediatric nephrology 2008; 23: 1951-1956. Go to original source... Go to PubMed...
    15. Sinha A, Gulati A, Saini S, Blanc C, Gupta A, Gurjar BS, Saini H, Kotresh ST, Ali U, Bhatia D, Ohri A, Kumar M, Agarwal I, Gulati S, Anand K, Vijayakumar M, Sinha R, Sethi S, Salmona M, George A, Bal V, Singh G, Dinda AK, Hari P, Rath S, Dragon‑Durey MA, Bagga A, Indian HUSR. Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti‑factor H autoantibody‑associated hemolytic uremic syndrome in children. Kidney international 2014; 85: 1151-1160. Go to original source... Go to PubMed...
    16. Raina R, Krishnappa V, Blaha T, Kann T, Hein W, Burke L, Bagga A. Atypical Hemolytic‑Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment. Therapeutic apheresis and dialysis: official peer‑reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2019; 23: 4-21. Go to original source... Go to PubMed...
    17. Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, Coppo R, Emma F, Johnson S, Karpman D, Landau D, Langman CB, Lapeyraque AL, Licht C, Nester C, Pecoraro C, Riedl M, van de Kar NC, Van de Walle J, Vivarelli M, Fremeaux‑Bacchi V, International HUS. An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatric nephrology 2016; 31: 15-39. Go to original source... Go to PubMed...
    18. Quaggin SE. DGKE and atypical HUS. Nature genetics 2013; 45: 475-476. Go to original source... Go to PubMed...
    19. Beck BB, van Spronsen F, Diepstra A, Berger RM, Komhoff M. Renal thrombotic microangiopathy in patients with cblC defect: review of an under‑recognized entity. Pediatric nephrology 2017; 32: 733-741. Go to original source... Go to PubMed...
    20. Milan Manani S, Virzi GM, Giuliani A, Clementi A, Brocca A, Dissegna D, Martino F, d'Amore ESG, Ronco C. Hemolytic Uremic Syndrome and Kidney Transplantation: A Case Series and Review of the Literature. Nephron 2017; 136: 245-253. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.